Cargando…

Characterizing hepatocellular carcinoma stem markers and their corresponding susceptibility to NK-cell based immunotherapy

INTRODUCTION: Hepatocellular carcinoma (HCC) is the most common primary liver cancer and is the fourth-leading cause of all cancer-related deaths around the world. Liver transplantation, surgery, and local ablation are curative therapies for early-stage HCC. However, post-treatment outcomes can vary...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiang, Jason, Chen, Po-Chun, Pham, Janet, Nguyen, Cat-Quynh, Kaur, Kawaljit, Raman, Steven S., Jewett, Anahid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637628/ https://www.ncbi.nlm.nih.gov/pubmed/37954598 http://dx.doi.org/10.3389/fimmu.2023.1284669

Ejemplares similares

Differences in Tumor Growth and Differentiation in NSG and Humanized-BLT Mice; Analysis of Human vs. Humanized-BLT-Derived NK Expansion and Functions
por: Kaur, Kawaljit, et al.
Publicado: (2022)

Osteoclast-expanded super-charged NK-cells preferentially select and expand CD8+ T cells
por: Kaur, Kawaljit, et al.
Publicado: (2020)

Suppression of Gingival NK Cells in Precancerous and Cancerous Stages of Pancreatic Cancer in KC and BLT-Humanized Mice
por: Kaur, Kawaljit, et al.
Publicado: (2017)

Sequential therapy with supercharged NK cells with either chemotherapy drug cisplatin or anti-PD-1 antibody decreases the tumor size and significantly enhances the NK function in Hu-BLT mice
por: Kaur, Kawaljit, et al.
Publicado: (2023)

ADCC against MICA/B Is Mediated against Differentiated Oral and Pancreatic and Not Stem-Like/Poorly Differentiated Tumors by the NK Cells; Loss in Cancer Patients due to Down-Modulation of CD16 Receptor
por: Kaur, Kawaljit, et al.
Publicado: (2021)

Defective Patient NK Function Is Reversed by AJ2 Probiotic Bacteria or Addition of Allogeneic Healthy Monocytes
por: Ko, Meng-Wei, et al.
Publicado: (2022)

Differential Cytotoxicity but Augmented IFN-γ Secretion by NK Cells after Interaction with Monocytes from Humans, and Those from Wild Type and Myeloid-Specific COX-2 Knockout Mice
por: Tseng, Han-Ching, et al.
Publicado: (2015)

Novel Strategy to Expand Super-Charged NK Cells with Significant Potential to Lyse and Differentiate Cancer Stem Cells: Differences in NK Expansion and Function between Healthy and Cancer Patients
por: Kaur, Kawaljit, et al.
Publicado: (2017)

Differentiation by NK cells is a prerequisite for effective targeting of cancer stem cells/poorly differentiated tumors by chemopreventive and chemotherapeutic drugs
por: Kozlowska, Anna Karolina, et al.
Publicado: (2017)

Augmented IFN-γ and TNF-α Induced by Probiotic Bacteria in NK Cells Mediate Differentiation of Stem-Like Tumors Leading to Inhibition of Tumor Growth and Reduction in Inflammatory Cytokine Release; Regulation by IL-10
por: Bui, Vickie T., et al.
Publicado: (2015)

Probiotic-Treated Super-Charged NK Cells Efficiently Clear Poorly Differentiated Pancreatic Tumors in Hu-BLT Mice
por: Kaur, Kawaljit, et al.
Publicado: (2019)

Phenotypic and Functional Alterations of Immune Effectors in Periodontitis; A Multifactorial and Complex Oral Disease
por: Kaur, Kawaljit, et al.
Publicado: (2021)

The Potential Effect of Novel Coronavirus SARS-CoV-2 on NK Cells; A Perspective on Potential Therapeutic Interventions
por: Jewett, Anahid
Publicado: (2020)

Bisphosphonate-induced differential modulation of immune cell function in gingiva and bone marrow in vivo: Role in osteoclast-mediated NK cell activation
por: Tseng, Han-Ching, et al.
Publicado: (2015)

Erratum: Bisphosphonate-induced differential modulation of immune cell function in gingiva and bone marrow in vivo: Role in osteoclast-mediated NK cell activation
por: Tseng, Han-Ching, et al.
Publicado: (2015)

Cysteine Cathepsins as Regulators of the Cytotoxicity of NK and T Cells
por: Perišić Nanut, Milica, et al.
Publicado: (2014)

Augmentation of IFN-γ by bone marrow derived immune cells in the presence of severe suppression of IFN-γ in gingivae induced by zoledronic acid and denosumab in Hu-BLT mice model of ONJ
por: Kaur, Kawaljit, et al.
Publicado: (2023)

Deficiencies in Natural Killer Cell Numbers, Expansion, and Function at the Pre-Neoplastic Stage of Pancreatic Cancer by KRAS Mutation in the Pancreas of Obese Mice
por: Kaur, Kawaljit, et al.
Publicado: (2018)

Split anergized natural killer cells halt inflammation by inducing stem cell differentiation, resistance to NK cell cytotoxicity and prevention of cytokine and chemokine secretion
por: Tseng, Han-Ching, et al.
Publicado: (2015)

Differential Targeting of Stem Cells and Differentiated Glioblastomas by NK Cells
por: Tseng, Han-Ching, et al.
Publicado: (2015)

Immunotherapy of Glioblastoma: Current Strategies and Challenges in Tumor Model Development
por: Majc, Bernarda, et al.
Publicado: (2021)

The Potential Role of Cytotoxic Immune Effectors in Induction, Progression and Pathogenesis of Amyotrophic Lateral Sclerosis (ALS)
por: Kaur, Kawaljit, et al.
Publicado: (2022)

T and NK Cell-Based Immunotherapy in Chronic Viral Hepatitis and Hepatocellular Carcinoma
por: Fisicaro, Paola, et al.
Publicado: (2022)

Natural Killer Cells: Diverse Functions in Tumor Immunity and Defects in Pre-neoplastic and Neoplastic Stages of Tumorigenesis
por: Jewett, Anahid, et al.
Publicado: (2019)

NK cell marker gene-based model shows good predictive ability in prognosis and response to immunotherapies in hepatocellular carcinoma
por: Li, Juan, et al.
Publicado: (2023)

Special Issue on Immune Responses in Tumors and Non-Transformed Inflammatory Microenvironments
por: Jewett, Anahid
Publicado: (2012)

Strategies to Rescue Mesenchymal Stem Cells (MSCs) and Dental Pulp Stem Cells (DPSCs) from NK Cell Mediated Cytotoxicity
por: Jewett, Anahid, et al.
Publicado: (2010)

Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy
por: Sun, Cheng, et al.
Publicado: (2015)

Molecular Remission Using Low-Dose Immunotherapy with Minimal Toxicities for Poor Prognosis IGHV—Unmutated Chronic Lymphocytic Leukemia
por: Maharaj, Dipnarine, et al.
Publicado: (2020)

Natural Killer Cells in Liver Disease and Hepatocellular Carcinoma and the NK Cell-Based Immunotherapy
por: Liu, Pingyi, et al.
Publicado: (2018)

The Function of NK Cells in Tumor Metastasis and NK Cell-Based Immunotherapy
por: Yu, Yanlin
Publicado: (2023)

Tumor Induced Inactivation of Natural Killer Cell Cytotoxic Function; Implication in Growth, Expansion and Differentiation of Cancer Stem Cells
por: Jewett, Anahid, et al.
Publicado: (2011)

NK Cell-Based Glioblastoma Immunotherapy
por: Golán, Irene, et al.
Publicado: (2018)

Mechanisms of Resistance to NK Cell Immunotherapy
por: Sordo-Bahamonde, Christian, et al.
Publicado: (2020)

NK Cell Dysfunction and Checkpoint Immunotherapy
por: Bi, Jiacheng, et al.
Publicado: (2019)

NK Cell-Based Immunotherapies in Cancer
por: Shin, Min Hwa, et al.
Publicado: (2020)

NK cell-based tumor immunotherapy
por: Zhang, Hao, et al.
Publicado: (2023)

Checkpoint immunotherapy for NK/T cell lymphoma—Time for a showdown?
por: Chan, Jason Yongsheng, et al.
Publicado: (2021)

Editorial: NK Cell-Based Cancer Immunotherapy
por: Borrego, Francisco, et al.
Publicado: (2016)

NK Cell-Based Immunotherapy in Cancer Metastasis
por: Lorenzo-Herrero, Seila, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_csdii2b3hfj151j5imgvp5k6bu